Indian drugmakers likely to stay competitive despite planned US tariffs, Dr Reddy's says
(Reuters) -Indian drugmakers are likely to remain competitive in the generics market in the face of U.S. President Donald Trump's plans to levy tariffs on pharmaceutical imports, Dr Reddy's Managing ...
The Financial Express13m
How will Trump’s tariff threat on pharmaceuticals impact Indian drugmakers? Dr Reddy’s reacts
Earlier this month, the US President said that he intends to impose a "25% or higher" levies on semiconductors and ...
Bitcoin sinks below $92,000 on U.S. trade concerns; Ethereum, Solana drop up to 13%
Bitcoin's market capitalization dropped to $1.825 trillion, with its dominance standing at 61.25%. The cryptocurrency's ...